Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
  • Wide range of unique reagents
  • Free Shipping
    Free shipping in EU on Orders > €500
  • Fast worldwide delivery
    Fast worldwide delivery
Nycodenz AG® Nycodenz AG® XtenCHO ™ Race Starter kit XtenCHO ™ Race Starter kit
View all Products

Tafasitamab Biosimilar – Anti-CD19 mAb – Research Grade

Reference:
Product Image
SDS-PAGE for Tafasitamab Biosimilar - Anti-CD19 mAb
Product Image
SDS-PAGE for Tafasitamab Biosimilar - Anti-CD19 mAb
Size

100ug, 1MG
Isotype

IgG1-G2-kappa
Brand

ProteoGenix
Product type

Primary Antibodies
Clonality

Monoclonal Antibody
Expression system

Mammalian cells
Applications

Elisa, WB
Tags:
Specification
Description
Documents
QC & Validation Data1
Reviews
Product nameTafasitamab Biosimilar - Anti-CD19 mAb - Research Grade
SourceCAS 1422527-84-1
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsTafasitamab,MOR-00208,MOR-208,XENP-5574,XMP-5574,XmAb-5574,Xmab-CD19,CD19,anti-CD19
ReferencePX-TA1365
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-G2-kappa
ClonalityMonoclonal Antibody

Description of Tafasitamab Biosimilar - Anti-CD19 mAb - Research Grade

General information on Anti-CD19[Homo sapiens] (Tafasitamab) Monoclonal Antibody

Tafasitamab is a humanized monoclonal antibody that targets CD19. It is used for the treatment of B-cell malignancies. The CD19 surface protein is highly expressed on the surface of B-cells where it enhances B-cell receptor signaling. CD19 is especially expressed in cases of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), diffuse large B-cell lymphoma (DLBCL). By its activity, tafasatimab induces the lysis of B-cells.

Datasheet Download
MSDS Download

SDS-PAGE for Tafasitamab Biosimilar - Anti-CD19 mAb

Tafasitamab Biosimilar - Anti-CD19 mAb, on SDS-PAGE under non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Tafasitamab Biosimilar – Anti-CD19 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD19 Protein – Human CD19 recombinant protein
Antigen

CD19 Protein – Human CD19 recombinant protein

PX-P4004 210€
View product
CD19 Recombinant Protein
Antigen

CD19 Recombinant Protein

PX-P4077 420€
View product

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.

    Cart (0 Items)

    Your cart is currently empty.

    View Products